About Combined oxidative phosphorylation defect type 23
Combined oxidative phosphorylation defect type 23 is a rare disease catalogued by Orphanet (ORPHA:444013). It is associated with the GTPBP3 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Combined oxidative phosphorylation defect type 23 trials.
Search ClinicalTrials.gov for "Combined oxidative phosphorylation defect type 23" or filter by Orphanet code ORPHA:444013 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Combined oxidative phosphorylation defect type 23 trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Combined oxidative phosphorylation defect type 23. Updated daily.